BIXITO Trademark

Trademark Overview


On Saturday, July 14, 2018, a trademark application was filed for BIXITO with the United States Patent and Trademark Office. The USPTO has given the BIXITO trademark a serial number of 79241856. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, August 6, 2021. This trademark is owned by Novartis AG. The BIXITO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
bixito

General Information


Serial Number79241856
Word MarkBIXITO
Filing DateSaturday, July 14, 2018
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, August 6, 2021
Registration Number5667994
Registration DateTuesday, February 5, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2018

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, August 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, January 3, 2022INTERNATIONAL REGISTRATION RENEWED
Wednesday, December 22, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sunday, December 12, 2021NOTIFICATION PROCESSED BY IB
Sunday, September 19, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Monday, August 23, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, August 23, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, July 26, 2019NOTIFICATION PROCESSED BY IB
Monday, March 18, 2019FINAL DISPOSITION NOTICE SENT TO IB
Monday, March 18, 2019FINAL DISPOSITION PROCESSED
Thursday, March 7, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, February 5, 2019REGISTERED-PRINCIPAL REGISTER
Friday, November 30, 2018NOTIFICATION PROCESSED BY IB
Tuesday, November 20, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 7, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 31, 2018NOTICE OF PUBLICATION
Saturday, October 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 13, 2018ASSIGNED TO EXAMINER
Saturday, October 13, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, October 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 29, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 27, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB